Clinical Trials for MinervaX

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: MinervaX

Clinical Trials (3)

NCT06592586
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
PHASE2/PHASE3Recruiting
338 participants
Started: Mar 7, 2025 · Completed: Jun 30, 2029
9 conditions1 sponsor5 locations
NCT06494475
GBS-NN/NN2 (50 µg of Each Fusion Protein [GBS-NN and GBS-NN2] in Combination With 500 µg Aluminum as Alhydrogel®) Given With and Without the Tdap Vaccine in Healthy Non-pregnant Women 18 to 49 Years of Age
PHASE2/PHASE3Not yet recruiting
564 participants
Started: Dec 17, 2024 · Completed: Jun 21, 2025
1 condition1 sponsor0 locations
NCT06280157
A Follow up Study of Group B Streptococcus (GBS)-NN/NN2 Vaccine in Healthy Volunteers
N/AEnrolling by invitation
55 participants
Started: Jan 18, 2024 · Completed: Jan 31, 2028
1 condition2 sponsors1 location